Written by Kai-Ping Huang. To fight against Covid-19, there is only one solution for every country striving for a return to normality: vaccination. Herd immunity is the goal as advanced countries aim to vaccinate at least 75 per cent of their citizens. The discovery of different variants worldwide makes booster shots increasingly necessary to prevent severe symptoms even for the fully vaccinated. Although speed is vital, it is also essential to determine the proper order of vaccinations.
Written by Chunhuei Chi. For Taiwan to move toward the post-pandemic era, it must be understood that its main challenge is political rather than biological. Besides fighting disinformation and external and internal attempts to divide Taiwan and undermine its control effectiveness, it needs to consider the vaccines’ critical role in ending this pandemic. Further, the criticism of its government’s vaccine under-preparedness has shifted Taiwanese to inward-looking and toward vaccine nationalism.
Written by Brian Hioe. Vaccines have proved a contentious issue in Taiwan from the beginning. As the first vaccines that arrived in Taiwan were AstraZeneca vaccines, the Taiwanese public was initially unwilling to get vaccinated. The public was discouraged from being vaccinated by reports of blood clots and other adverse reactions after using AstraZeneca. As Taiwan had gone for more than a year mostly COVID-free, it is probable that members of the public did not see the need to get vaccinated.
Written by Mark Wenyi Lai. Because of Taiwan’s COVID-19 pandemic control policies, the ruling and opposition parties agree on a national partial lockdown and vaccine distribution. However, they disagree on vaccine purchase and testing policy. This essay argued that there is more consensus than discord and the reason rested on Taiwan’s unique political-economic status. Here are their debates.
Written by Denis Simon. In early 2021, Taiwan’s health care system was ranked number one globally for the third year in a row by NUMBEO’s Annual Online Survey. Its overall performance buoyed the island’s ability to consistently earn such a high ranking during the first 12-14 months of the Covid-19 global pandemic beginning in 2020. Taiwan officials initially were able to ward off any significant damage from the pandemic by pursuing a highly aggressive strategy to keep the virus at bay. While other international rankings, such as the World Index of Healthcare Innovation, do not rank Taiwan as number one in its rating system, there is consensus across the board internationally that the government has proven itself highly effective at managing its single-payer health care system, mainly due to its innovative approach to digital health records.
Written by Wen-Chin Wu, Greg Sheen, Hans H. Tung, Chien-Hui Wu. As COVID-19 began to spread from China to the world in early 2020, experts predicted that Taiwan would have “the world’s second-worst outbreak after China” ). Nevertheless, Taiwan was almost COVID-19-free until mid-May 2021 due to a set of successful policies, such as strict border control, population-based contact tracing of confirmed cases, and encouragement to wear facial masks. The “normal” pre-COVID-19 life lasted for almost one year until May 19, 2021, when Taiwan declared a nationwide COVID-19 Level 3 alert. The total number of confirmed COVID-19 cases in Taiwan since early 2020 had soared from 1,132 on May 1 to 8,511 on May 31, 2021.
Written by Min-hua Chiang. Taiwan government revised up economic growth forecast in 2021 to 5.5% in June despite the sudden surge of covid-19 cases since mid-May. This is the fastest growth path since and second only to the post-crisis rebound in 2010 (see Figure 1). The economy is bolstered by thriving exports outlook. Growing domestic investment is another anchor of Taiwan’s economy thanks to the continuous investment repatriation. The greater government consumption is expected to offset the potential fall in private consumption following the constraints on outdoor activities. Taiwan Centres for Disease Control (CDC)’s capability to put the domestic outbreak under control in a month further gives confidence that moderate economic growth this year could be expected.
Written by Ian Inkster. On 28 May, just after the Taiwanese authorities had apparently rejected outright Beijing’s offer to supply Covid 19 vaccines to Taiwan, Hsiao Bi-khim was urgently requesting from the USA ‘access to safe and effective vaccines.’ By 3 June, we knew that Sinovac and Sinopharm vaccines had been approved by both WHO and Covax Facility for distribution to other nations, that many millions of vaccines have been sent out from China to Africa and Asia, and that whatever the political interpretation, these vaccines were offered early to Taiwan free of charge.
Taiwan Insight 